Skip to content

Effect and related mechanisms of cortical-cerebellar dual-site repetitive transcranial magnetic stimulation on walking ability in stroke patients

Effect and related mechanisms of cortical-cerebellar dual-site repetitive transcranial magnetic stimulation on walking ability in stroke patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126540
Enrollment
Unknown
Registered
2026-06-10
Start date
2026-06-10
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Experimental group:Cortical-cerebellar dual-site rTMS
Control group:Cortical single-site rTMS with cerebellar sham stimulation

Sponsors

Beijing Bo'ai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. With first-ever stroke-related hemiplegia confirmed by cranial CT or MRI; 2. Aged 18-80 years; 3. Within 2 weeks to 6 months after onset; 4. Brunnstrom stage >= IV for the affected lower limb; 5. Impaired motor and balance function of the affected lower limb (FMA-LE: 21–33; BBS: 21–55); 6. Holden Walking Functional Classification grade III-IV; 7. Stable condition; 8. Provision of written informed consent.

Exclusion criteria

Exclusion criteria: 1. With cerebellar stroke; 2. Severe cognitive impairment and unable to cooperate with examinations and treatment; 3. Previously diagnosed with other neurological disorders affecting walking ability; 4. Severe respiratory or cardiovascular comorbidities; 5. Severe lower-limb arthritis or other severe musculoskeletal disorders affecting walking ability; 6. Visual impairment affecting walking ability; 7. History of epilepsy; 8. Intracranial metallic implants, cardiac pacemakers, or cochlear implants; 9. Skull defects; 10. Increased intracranial pressure; 11. Intracranial tumor; 12. Pregnancy.

Design outcomes

Primary

MeasureTime frame
Motor evoked potential;Timed up and go test;10-meter walk test;Incidence of adverse events;Resting motor threshold;Gait analysis;

Secondary

MeasureTime frame
Modified Barthel Index;Berg balance scale;Fugl-Meyer assessment for lower extremity;

Countries

China

Contacts

Public ContactZhao Xiaoxi

Beijing Bo'ai Hospital

zhaoxxmy@163.com+86 10 8756 9418

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 21, 2026